Additional Countries Sign Sputnik V Vaccine Distribution Agreements

Two additional countries announced Sputnik V vaccine distribution agreements during late December 2020. Algeria and Bolivia joined an extensive list of countries agreeing to purchase the Sputnik V vaccine for vaccination programs scheduled for 2021.

'The Sputnik V vaccine has a unique set of parameters,' stated the Russian Direct Investment Fund (RDIF) press statement issued on December 30, 2020.

Sputnik V is based on a robust, safe, and well-studied human adenoviral vector platform. And the availability of a lyophilized (dry) form of the vaccine significantly facilitates the logistics of its distribution in international markets due to simplified requirements for its storage temperature (+ 2 + 8 degrees Celsius).

"The safe and highly effective Sputnik V vaccine will protect more than 20% of Bolivia's population. We look forward to expanding cooperation on the vaccine with other states of the Latin American continent in the future," added Kirill Dmitriev, CEO of the RDIF.